Dimercaprol
FDA-approved product (injectable, injection), marketed as Bal.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 0 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLNo approved indication recorded
ChEMBL records no approved indication for Dimercaprol. Its therapeutic class is shown instead.
- WHO therapeutic group
- Antidotes
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
No supported pathogen reaches ≥40% AI-predicted activity for Dimercaprol, so it is not among the repurposing candidates. Its predictions are shown below.
AI-predicted activity
AI prediction · nothing measured- MRSA15.7% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli13.3% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae8.8% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis16.7% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Dimercaprol with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- UrsodiolExisting use: Biliary liver cirrhosis, Primary biliary cirrhosis69.2% AI-predicted activityagainst MRSA50+ registered studies
- OlaparibExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 9 more69.2% AI-predicted activityagainst MRSA50+ registered studies
- Ganirelix AcetateExisting use: Female infertility, Positive regulation of ovulation, Reproductive Techniques, Assisted69.1% AI-predicted activityagainst MRSA50+ registered studies
- DanicopanExisting use: Acquired paroxysmal nocturnal hemoglobinuria, Hemoglobinuria, Paroxysmal, Hemolysis68.7% AI-predicted activityagainst MRSA30 registered studies
- Simeprevir SodiumExisting use: Chronic hepatitis C virus infection68.6% AI-predicted activityagainst MRSANo documented evidence found
- Lanreotide AcetateExisting use: Acromegaly, Carcinoid syndrome68.3% AI-predicted activityagainst MRSA50+ registered studies
- Cholic AcidExisting use: Abnormality of the gastrointestinal tract, Inborn errors of metabolism, Liver disease and 1 more68.0% AI-predicted activityagainst MRSA50+ registered studies
- EptifibatideExisting use: Acute coronary syndrome, Acute myocardial infarction, Intermediate coronary syndrome and 2 more67.8% AI-predicted activityagainst MRSA35 registered studies
- AbarelixExisting use: Neoplasm67.7% AI-predicted activityagainst MRSA5 registered studies
- EverolimusExisting use: Adenoma sebaceum, Anaplastic astrocytoma, Angiomyolipoma and 18 more67.5% AI-predicted activityagainst MRSA50+ registered studies
- Paliperidone PalmitateExisting use: Mental or behavioural disorder, Psychosis, Schizoaffective disorder and 1 more67.3% AI-predicted activityagainst MRSA50+ registered studies
- PaliperidoneExisting use: Mental or behavioural disorder, Psychosis, Schizoaffective disorder and 1 more67.2% AI-predicted activityagainst MRSA50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Perpetual Observational Study - Ventilator Associated Pneumonia
NCT05719259 · start 2022-08-03
Registered record
- Registry ID
- NCT05719259
- Conditions
- Ventilator Associated Pneumonia
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2022-08-03
- Completion
- 2027-03-01
- Enrolment
- 20,000
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVentilator Associated PneumoniaInterventionNot recordedPhaseNot recordedRegistry statusRecruitingM-ROSE Combined With mNGS in Severe Hospital-acquired Pneumonia
NCT05300776 · start 2022-05
Registered record
- Registry ID
- NCT05300776
- Conditions
- Pneumonia
- Interventions
- M-ROSE analysis
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2022-05
- Completion
- 2024-12-31
- Enrolment
- 166
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPneumoniaInterventionM-ROSE analysisPhaseNot applicableRegistry statusUnknownThe Diagnosis of Superinfections in Mechanically Ventilated Covid-19 Patients
NCT05148975 · start 2021-12-11
Registered record
- Registry ID
- NCT05148975
- Conditions
- COVID-19 Pneumonia; Superinfection; ARDS, Human
- Interventions
- Bronchoalveolar lavage fluid diagnostics
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2021-12-11
- Completion
- 2023-03-31
- Enrolment
- 150
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCOVID-19 Pneumonia; Superinfection; ARDS, HumanInterventionBronchoalveolar lavage fluid diagnosticsPhaseNot recordedRegistry statusUnknownRandomized Trial of COVID-19 Booster Vaccinations (Cobovax Study)
NCT05057169 · start 2021-11-18
Registered record
- Registry ID
- NCT05057169
- Conditions
- COVID-19 Vaccination
- Interventions
- BNT162b2; CoronaVac
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2021-11-18
- Completion
- 2025-12-31
- Enrolment
- 451
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCOVID-19 VaccinationInterventionBNT162b2; CoronaVacPhasePhase 4Registry statusCompletedThymic Function in Patients With COVID-19
NCT04716907 · start 2021-03-19
Registered record
- Registry ID
- NCT04716907
- Conditions
- Covid19
- Interventions
- Single-Nucleotide Polymorphisms (SNP) within the TCRA/D region; Blood sample; CT Scan; Bronchial fibroscopy
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2021-03-19
- Completion
- 2022-04-02
- Enrolment
- 85
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCovid19InterventionSingle-Nucleotide Polymorphisms (SNP) within the TCRA/D region; Blood sample; CT Scan; Bronchial fibroscopyPhaseNot recordedRegistry statusCompletedBronchoalveolar Lavage in Recovered From COVID-19 Pneumonia
NCT06022198 · start 2021-01-01
Registered record
- Registry ID
- NCT06022198
- Conditions
- Bronchoalveolar Lavage
- Interventions
- Bronchoalveolar Lavage
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2021-01-01
- Completion
- 2023-01-01
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBronchoalveolar LavageInterventionBronchoalveolar LavagePhaseNot applicableRegistry statusCompletedRapid Diagnostic Supporting Antimicrobial Stewardship in Patients With Pneumonia
NCT05937126 · start 2020-09-15
Registered record
- Registry ID
- NCT05937126
- Conditions
- Lower Respiratory Tract Infections
- Interventions
- FilmArray Pneumonia Panel; Culture and antimicrobial susceptibility testing
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2020-09-15
- Completion
- 2022-09-19
- Enrolment
- 1,203
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionLower Respiratory Tract InfectionsInterventionFilmArray Pneumonia Panel; Culture and antimicrobial susceptibility testingPhaseNot recordedRegistry statusCompletedFiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients
NCT04502368 · start 2020-09-01
Registered record
- Registry ID
- NCT04502368
- Conditions
- Fiberoptic Bronchoscopy (FOB); Bronchoalveolar Lavage (BAL); Respiratory Disease
- Interventions
- Fiberoptic Bronchoscopy (FOB); Bronchoalveolar Lavage (BAL); Electrical Impedance Tomography (EIT); Arterial Blood Gas test (ABG)
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2020-09-01
- Completion
- 2021-04-30
- Enrolment
- 15
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionFiberoptic Bronchoscopy (FOB); Bronchoalveolar Lavage (BAL); Respiratory DiseaseInterventionFiberoptic Bronchoscopy (FOB); Bronchoalveolar Lavage (BAL); Electrical Impedance Tomography (EIT); Arterial Blood Gas test (ABG)PhaseNot recordedRegistry statusUnknownMicrobiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches
NCT04410263 · start 2020-04-09
Registered record
- Registry ID
- NCT04410263
- Conditions
- Corona Virus Infection; ARDS; Coinfection
- Interventions
- Sampling (EDTA blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine)
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2020-04-09
- Completion
- 2023-12-31
- Enrolment
- 300
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCorona Virus Infection; ARDS; CoinfectionInterventionSampling (EDTA blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine)PhaseNot recordedRegistry statusUnknownStandardized BAL Procedure for Critical Patients to Diagnose Pneumonia Pathogens
NCT04200742 · start 2019-09-16
Registered record
- Registry ID
- NCT04200742
- Conditions
- Bronchoalveolar Lavage; Pneumonia
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2019-09-16
- Completion
- 2020-06-01
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBronchoalveolar Lavage; PneumoniaInterventionNot recordedPhaseNot recordedRegistry statusUnknownImaging Activated Macrophages in the Lungs
NCT03494114 · start 2018-11-29
Registered record
- Registry ID
- NCT03494114
- Conditions
- COPD
- Interventions
- Ga-EC2115
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Terminated
- Start
- 2018-11-29
- Completion
- 2021-01-13
- Enrolment
- 13
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCOPDInterventionGa-EC2115PhasePhase 1Registry statusTerminatedPattern of Isolated Fungi From Bronchoalveolar Lavage Among Patients With Lung Cancer
NCT05575388 · start 2018-03-01
Registered record
- Registry ID
- NCT05575388
- Conditions
- Lung Cancer
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2018-03-01
- Completion
- 2020-10-01
- Enrolment
- 100
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionLung CancerInterventionNot recordedPhaseNot recordedRegistry statusCompletedAirway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation
NCT03643302 · start 2018-02-01
Registered record
- Registry ID
- NCT03643302
- Conditions
- Bronchiectasis Adult
- Interventions
- Version BF-1T26 electronic bronchoscope
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2018-02-01
- Completion
- 2019-03-18
- Enrolment
- 189
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBronchiectasis AdultInterventionVersion BF-1T26 electronic bronchoscopePhaseNot recordedRegistry statusCompletedPreliminary Study on the Clinical Application Value of "Showering Cells" in Diagnosing Aspiration Pneumonia
NCT07707206 · start 2018-01-12
Registered record
- Registry ID
- NCT07707206
- Conditions
- Pneumonia, Aspiration
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2018-01-12
- Completion
- 2026-03-21
- Enrolment
- 430
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPneumonia, AspirationInterventionNot recordedPhaseNot recordedRegistry statusCompletedSecond-generation Sequencing Guides the Treatment of Severe Pneumonia
NCT03884881 · start 2018-01-01
Registered record
- Registry ID
- NCT03884881
- Conditions
- Pneumonia; Metagenomic Next Generation Sequencing
- Interventions
- metagenomic next generation sequencing; Conventional pathogen detection; Meropenem,Imipenem,Caspofene,Osstat
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2018-01-01
- Completion
- 2019-12-01
- Enrolment
- 400
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPneumonia; Metagenomic Next Generation SequencingInterventionmetagenomic next generation sequencing; Conventional pathogen detection; Meropenem,Imipenem,Caspofene,OsstatPhaseNot applicableRegistry statusUnknown